Barbican, London, UK

Spotlight: Argent BioPharma — Pioneering Cannabinoid Innovation for Refractory Epilepsy

A New Era in Neurological Therapeutics In the ever-evolving world of biotech, few companies embody innovation and focus like Argent BioPharma. A clinical-stage biopharmaceutical company based in Australia, Argent is transforming how central nervous system (CNS) and immune-related disorders are treated. With a foundation in polypharmacology and nanotechnology, it is addressing significant unmet needs—most notably, […]

Where Investors Are Betting Big in Health and Biotech

The health and biotech sectors are in the midst of a historic transformation, and in 2025, investors are doubling down on what they see as the most disruptive, scalable, and defensible innovations in decades. From AI-driven diagnostics to precision therapeutics and digital health infrastructure, capital is flowing into areas where science meets software—and where unmet […]

From Lab to App: How Health Tech is Accelerating Patient Outcomes

From Lab to App: How Health Tech is Accelerating Patient Outcomes In today’s healthcare landscape, speed saves lives—and technology is delivering speed like never before. What used to take years in labs and clinics is now being compressed into months or even weeks, thanks to the explosion of health tech. From diagnostics to drug development […]